RB1 and retinoblastoma: While loss-of-function RB1 mutations are universally detected in retinoblastoma and SCLC, RB1 is much more frequently inactivated in human tumors by p16 loss providing evidence that p16 also has critical tumor suppressive functions that are not mediated through RB1 in humans.